instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the dosage of drug 'FLUCONAZOLE'? | Meropenem-induced pancytopenia in a preterm neonate: a case report.
BACKGROUND
A post-marketing surveillance study has reported an association between meropenem use and the incidence of hematologic abnormalities, including leukopenia, thrombocytopenia, hemolysis, and neutropenia, but the precise incidence in neonates i... | UNK, FROM THE SECOND DAY OF LIFE | DrugDosageText | CC BY | 33509295 | 18,915,789 | 2021-01-29 |
What was the outcome of reaction 'Anaemia neonatal'? | Meropenem-induced pancytopenia in a preterm neonate: a case report.
BACKGROUND
A post-marketing surveillance study has reported an association between meropenem use and the incidence of hematologic abnormalities, including leukopenia, thrombocytopenia, hemolysis, and neutropenia, but the precise incidence in neonates i... | Recovered | ReactionOutcome | CC BY | 33509295 | 18,915,789 | 2021-01-29 |
What was the outcome of reaction 'Neutropenia neonatal'? | Meropenem-induced pancytopenia in a preterm neonate: a case report.
BACKGROUND
A post-marketing surveillance study has reported an association between meropenem use and the incidence of hematologic abnormalities, including leukopenia, thrombocytopenia, hemolysis, and neutropenia, but the precise incidence in neonates i... | Recovered | ReactionOutcome | CC BY | 33509295 | 18,915,789 | 2021-01-29 |
What was the outcome of reaction 'Pancytopenia'? | Meropenem-induced pancytopenia in a preterm neonate: a case report.
BACKGROUND
A post-marketing surveillance study has reported an association between meropenem use and the incidence of hematologic abnormalities, including leukopenia, thrombocytopenia, hemolysis, and neutropenia, but the precise incidence in neonates i... | Recovered | ReactionOutcome | CC BY | 33509295 | 18,915,789 | 2021-01-29 |
What was the outcome of reaction 'Thrombocytopenia neonatal'? | Meropenem-induced pancytopenia in a preterm neonate: a case report.
BACKGROUND
A post-marketing surveillance study has reported an association between meropenem use and the incidence of hematologic abnormalities, including leukopenia, thrombocytopenia, hemolysis, and neutropenia, but the precise incidence in neonates i... | Recovered | ReactionOutcome | CC BY | 33509295 | 18,915,789 | 2021-01-29 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Febrile neutropenia'. | Clinical pattern of failure after a durable response to immune check inhibitors in non-small cell lung cancer patients.
Although immune checkpoint inhibitors (ICIs) can induce durable responses in non-small-cell lung cancer (NSCLC) patients, a significant proportion of responders still experience progressive disease af... | NIVOLUMAB | DrugsGivenReaction | CC BY | 33510255 | 18,971,720 | 2021-01-28 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonitis'. | Clinical pattern of failure after a durable response to immune check inhibitors in non-small cell lung cancer patients.
Although immune checkpoint inhibitors (ICIs) can induce durable responses in non-small-cell lung cancer (NSCLC) patients, a significant proportion of responders still experience progressive disease af... | NIVOLUMAB | DrugsGivenReaction | CC BY | 33510255 | 18,970,334 | 2021-01-28 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Thyroiditis'. | Clinical pattern of failure after a durable response to immune check inhibitors in non-small cell lung cancer patients.
Although immune checkpoint inhibitors (ICIs) can induce durable responses in non-small-cell lung cancer (NSCLC) patients, a significant proportion of responders still experience progressive disease af... | IPILIMUMAB, NIVOLUMAB | DrugsGivenReaction | CC BY | 33510255 | 18,971,109 | 2021-01-28 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Foetal exposure during pregnancy'. | Pregnancy-Associated Chest Pain: A Case of Spontaneous Coronary Artery Dissection.
Spontaneous Coronary Artery Dissection (SCAD) is an important cause of myocardial infarction that typically affects women without traditional cardiovascular risk factors. It is the most common cause of myocardial infarction in pregnant a... | METOPROLOL | DrugsGivenReaction | CC BY | 33510913 | 19,299,657 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hyperbilirubinaemia neonatal'. | Pregnancy-Associated Chest Pain: A Case of Spontaneous Coronary Artery Dissection.
Spontaneous Coronary Artery Dissection (SCAD) is an important cause of myocardial infarction that typically affects women without traditional cardiovascular risk factors. It is the most common cause of myocardial infarction in pregnant a... | METOPROLOL | DrugsGivenReaction | CC BY | 33510913 | 19,299,657 | 2021 |
What was the administration route of drug 'METOPROLOL'? | Pregnancy-Associated Chest Pain: A Case of Spontaneous Coronary Artery Dissection.
Spontaneous Coronary Artery Dissection (SCAD) is an important cause of myocardial infarction that typically affects women without traditional cardiovascular risk factors. It is the most common cause of myocardial infarction in pregnant a... | Transplacental | DrugAdministrationRoute | CC BY | 33510913 | 19,299,657 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Humerus fracture'. | Transient Hypophosphatemia: A Dangerous Event in Multiple Myeloma.
Patients with malignancies frequently experience multiple electrolyte disturbances. In multiple myeloma, hypercalcemia and hyperphosphatemia are one of the most common metabolic disturbances observed as part of pathogenesis of the disease. However, in r... | BORTEZOMIB, CYCLOPHOSPHAMIDE, DEXAMETHASONE, SODIUM CHLORIDE, ZOLEDRONIC ACID | DrugsGivenReaction | CC BY | 33510918 | 19,414,397 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pathological fracture'. | Transient Hypophosphatemia: A Dangerous Event in Multiple Myeloma.
Patients with malignancies frequently experience multiple electrolyte disturbances. In multiple myeloma, hypercalcemia and hyperphosphatemia are one of the most common metabolic disturbances observed as part of pathogenesis of the disease. However, in r... | BORTEZOMIB, CYCLOPHOSPHAMIDE, DEXAMETHASONE, SODIUM CHLORIDE, ZOLEDRONIC ACID | DrugsGivenReaction | CC BY | 33510918 | 19,401,944 | 2021 |
What was the administration route of drug 'SODIUM CHLORIDE'? | Transient Hypophosphatemia: A Dangerous Event in Multiple Myeloma.
Patients with malignancies frequently experience multiple electrolyte disturbances. In multiple myeloma, hypercalcemia and hyperphosphatemia are one of the most common metabolic disturbances observed as part of pathogenesis of the disease. However, in r... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33510918 | 19,401,944 | 2021 |
What was the outcome of reaction 'Hypophosphataemia'? | Transient Hypophosphatemia: A Dangerous Event in Multiple Myeloma.
Patients with malignancies frequently experience multiple electrolyte disturbances. In multiple myeloma, hypercalcemia and hyperphosphatemia are one of the most common metabolic disturbances observed as part of pathogenesis of the disease. However, in r... | Recovered | ReactionOutcome | CC BY | 33510918 | 19,401,944 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Toxicity to various agents'. | Rhabdomyolysis following single administration of pembrolizumab: Is severe immune-reaction a marker for durable treatment response?
•Immune checkpoint inhibitors are approved for all mismatch repair deficient tumors.•Although rare, autoimmune myositis complicating pembrolizumab therapy may be fatal.•In this case, pembr... | BEVACIZUMAB, CISPLATIN, LEVONORGESTREL, PACLITAXEL | DrugsGivenReaction | CC BY-NC-ND | 33511262 | 18,969,398 | 2021-02 |
What was the administration route of drug 'BEVACIZUMAB'? | Rhabdomyolysis following single administration of pembrolizumab: Is severe immune-reaction a marker for durable treatment response?
•Immune checkpoint inhibitors are approved for all mismatch repair deficient tumors.•Although rare, autoimmune myositis complicating pembrolizumab therapy may be fatal.•In this case, pembr... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 33511262 | 18,969,398 | 2021-02 |
What was the administration route of drug 'CISPLATIN'? | Rhabdomyolysis following single administration of pembrolizumab: Is severe immune-reaction a marker for durable treatment response?
•Immune checkpoint inhibitors are approved for all mismatch repair deficient tumors.•Although rare, autoimmune myositis complicating pembrolizumab therapy may be fatal.•In this case, pembr... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 33511262 | 18,969,398 | 2021-02 |
What was the administration route of drug 'LEVONORGESTREL'? | Rhabdomyolysis following single administration of pembrolizumab: Is severe immune-reaction a marker for durable treatment response?
•Immune checkpoint inhibitors are approved for all mismatch repair deficient tumors.•Although rare, autoimmune myositis complicating pembrolizumab therapy may be fatal.•In this case, pembr... | Intra-uterine | DrugAdministrationRoute | CC BY-NC-ND | 33511262 | 18,969,398 | 2021-02 |
What was the administration route of drug 'PACLITAXEL'? | Rhabdomyolysis following single administration of pembrolizumab: Is severe immune-reaction a marker for durable treatment response?
•Immune checkpoint inhibitors are approved for all mismatch repair deficient tumors.•Although rare, autoimmune myositis complicating pembrolizumab therapy may be fatal.•In this case, pembr... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 33511262 | 18,969,398 | 2021-02 |
What was the dosage of drug 'BEVACIZUMAB'? | Rhabdomyolysis following single administration of pembrolizumab: Is severe immune-reaction a marker for durable treatment response?
•Immune checkpoint inhibitors are approved for all mismatch repair deficient tumors.•Although rare, autoimmune myositis complicating pembrolizumab therapy may be fatal.•In this case, pembr... | 21?DAY CYCLE | DrugDosageText | CC BY-NC-ND | 33511262 | 18,969,398 | 2021-02 |
What was the dosage of drug 'CISPLATIN'? | Rhabdomyolysis following single administration of pembrolizumab: Is severe immune-reaction a marker for durable treatment response?
•Immune checkpoint inhibitors are approved for all mismatch repair deficient tumors.•Although rare, autoimmune myositis complicating pembrolizumab therapy may be fatal.•In this case, pembr... | 21?DAY CYCLE | DrugDosageText | CC BY-NC-ND | 33511262 | 18,969,398 | 2021-02 |
What was the dosage of drug 'LEVONORGESTREL'? | Rhabdomyolysis following single administration of pembrolizumab: Is severe immune-reaction a marker for durable treatment response?
•Immune checkpoint inhibitors are approved for all mismatch repair deficient tumors.•Although rare, autoimmune myositis complicating pembrolizumab therapy may be fatal.•In this case, pembr... | LEVONORGESTREL?RELEASING INTRAUTERINE DEVICE | DrugDosageText | CC BY-NC-ND | 33511262 | 18,969,398 | 2021-02 |
What was the dosage of drug 'PACLITAXEL'? | Rhabdomyolysis following single administration of pembrolizumab: Is severe immune-reaction a marker for durable treatment response?
•Immune checkpoint inhibitors are approved for all mismatch repair deficient tumors.•Although rare, autoimmune myositis complicating pembrolizumab therapy may be fatal.•In this case, pembr... | 21?DAY CYCLE | DrugDosageText | CC BY-NC-ND | 33511262 | 18,969,398 | 2021-02 |
What was the outcome of reaction 'Toxicity to various agents'? | Rhabdomyolysis following single administration of pembrolizumab: Is severe immune-reaction a marker for durable treatment response?
•Immune checkpoint inhibitors are approved for all mismatch repair deficient tumors.•Although rare, autoimmune myositis complicating pembrolizumab therapy may be fatal.•In this case, pembr... | Recovered | ReactionOutcome | CC BY-NC-ND | 33511262 | 18,969,398 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Delirium'. | Implementation of the "awakening and breathing trials, choice of drugs, delirium management, and early exercise/mobility" bundle in the pediatric intensive care unit of tertiary hospitals in southwestern China: a cross-sectional survey.
OBJECTIVE
To investigate management and implementation of the "awakening and breath... | ACETAMINOPHEN, CHLORAL HYDRATE, DEXMEDETOMIDINE, DIAZEPAM, FENTANYL, IBUPROFEN, MIDAZOLAM, MORPHINE, PHENOBARBITAL, PROPOFOL, REMIFENTANIL, SUFENTANIL | DrugsGivenReaction | CC BY-NC | 33513055 | 19,607,216 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Arrhythmia'. | Interim Effectiveness and Safety Comparison of Bedaquiline-Containing Regimens for Treatment of Diabetic Versus Non-Diabetic MDR/XDR-TB Patients in China: A Multicenter Retrospective Cohort Study.
BACKGROUND
Diabetes mellitus (DM), a common tuberculosis (TB) comorbidity, is associated with delayed bacillary clearance d... | AMIKACIN, AMINOSALICYLIC ACID, AMOXICILLIN\CLAVULANATE POTASSIUM, BEDAQUILINE FUMARATE, CLOFAZIMINE, CYCLOSERINE, ETHAMBUTOL HYDROCHLORIDE, ISONIAZID, LEVOFLOXACIN, LINEZOLID, MEROPENEM, MOXIFLOXACIN, PASINIAZID, PROTIONAMIDE, PYRAZINAMIDE, STREPTOMYCIN SULFATE | DrugsGivenReaction | CC BY-NC | 33515206 | 18,875,374 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Arthralgia'. | Interim Effectiveness and Safety Comparison of Bedaquiline-Containing Regimens for Treatment of Diabetic Versus Non-Diabetic MDR/XDR-TB Patients in China: A Multicenter Retrospective Cohort Study.
BACKGROUND
Diabetes mellitus (DM), a common tuberculosis (TB) comorbidity, is associated with delayed bacillary clearance d... | AMIKACIN, AMINOSALICYLIC ACID, AMOXICILLIN\CLAVULANATE POTASSIUM, BEDAQUILINE FUMARATE, CLOFAZIMINE, CYCLOSERINE, ETHAMBUTOL HYDROCHLORIDE, ISONIAZID, LEVOFLOXACIN, LINEZOLID, MEROPENEM, MOXIFLOXACIN, PASINIAZID, PROTIONAMIDE, PYRAZINAMIDE, STREPTOMYCIN SULFATE | DrugsGivenReaction | CC BY-NC | 33515206 | 18,875,374 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Blood disorder'. | Interim Effectiveness and Safety Comparison of Bedaquiline-Containing Regimens for Treatment of Diabetic Versus Non-Diabetic MDR/XDR-TB Patients in China: A Multicenter Retrospective Cohort Study.
BACKGROUND
Diabetes mellitus (DM), a common tuberculosis (TB) comorbidity, is associated with delayed bacillary clearance d... | AMIKACIN, AMINOSALICYLIC ACID, AMOXICILLIN\CLAVULANATE POTASSIUM, BEDAQUILINE FUMARATE, CLOFAZIMINE, CYCLOSERINE, ETHAMBUTOL HYDROCHLORIDE, ISONIAZID, LEVOFLOXACIN, LINEZOLID, MEROPENEM, MOXIFLOXACIN, PASINIAZID, PROTIONAMIDE, PYRAZINAMIDE, STREPTOMYCIN SULFATE | DrugsGivenReaction | CC BY-NC | 33515206 | 18,875,374 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cerebral infarction'. | Interim Effectiveness and Safety Comparison of Bedaquiline-Containing Regimens for Treatment of Diabetic Versus Non-Diabetic MDR/XDR-TB Patients in China: A Multicenter Retrospective Cohort Study.
BACKGROUND
Diabetes mellitus (DM), a common tuberculosis (TB) comorbidity, is associated with delayed bacillary clearance d... | AMIKACIN, AMINOSALICYLIC ACID, AMOXICILLIN\CLAVULANATE POTASSIUM, BEDAQUILINE FUMARATE, CLOFAZIMINE, CYCLOSERINE, ETHAMBUTOL HYDROCHLORIDE, ISONIAZID, LEVOFLOXACIN, LINEZOLID, MEROPENEM, MOXIFLOXACIN, PASINIAZID, PROTIONAMIDE, PYRAZINAMIDE, STREPTOMYCIN SULFATE | DrugsGivenReaction | CC BY-NC | 33515206 | 18,875,374 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dizziness'. | Interim Effectiveness and Safety Comparison of Bedaquiline-Containing Regimens for Treatment of Diabetic Versus Non-Diabetic MDR/XDR-TB Patients in China: A Multicenter Retrospective Cohort Study.
BACKGROUND
Diabetes mellitus (DM), a common tuberculosis (TB) comorbidity, is associated with delayed bacillary clearance d... | AMIKACIN, AMINOSALICYLIC ACID, AMOXICILLIN\CLAVULANATE POTASSIUM, BEDAQUILINE FUMARATE, CLOFAZIMINE, CYCLOSERINE, ETHAMBUTOL HYDROCHLORIDE, ISONIAZID, LEVOFLOXACIN, LINEZOLID, MEROPENEM, MOXIFLOXACIN, PASINIAZID, PROTIONAMIDE, PYRAZINAMIDE, STREPTOMYCIN SULFATE | DrugsGivenReaction | CC BY-NC | 33515206 | 18,875,374 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Electrocardiogram QT prolonged'. | Interim Effectiveness and Safety Comparison of Bedaquiline-Containing Regimens for Treatment of Diabetic Versus Non-Diabetic MDR/XDR-TB Patients in China: A Multicenter Retrospective Cohort Study.
BACKGROUND
Diabetes mellitus (DM), a common tuberculosis (TB) comorbidity, is associated with delayed bacillary clearance d... | AMIKACIN, AMINOSALICYLIC ACID, AMOXICILLIN\CLAVULANATE POTASSIUM, BEDAQUILINE FUMARATE, CLOFAZIMINE, CYCLOSERINE, ETHAMBUTOL HYDROCHLORIDE, ISONIAZID, LEVOFLOXACIN, LINEZOLID, MEROPENEM, MOXIFLOXACIN, PASINIAZID, PROTIONAMIDE, PYRAZINAMIDE, STREPTOMYCIN SULFATE | DrugsGivenReaction | CC BY-NC | 33515206 | 18,875,374 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Electrocardiogram T wave abnormal'. | Interim Effectiveness and Safety Comparison of Bedaquiline-Containing Regimens for Treatment of Diabetic Versus Non-Diabetic MDR/XDR-TB Patients in China: A Multicenter Retrospective Cohort Study.
BACKGROUND
Diabetes mellitus (DM), a common tuberculosis (TB) comorbidity, is associated with delayed bacillary clearance d... | AMIKACIN, AMINOSALICYLIC ACID, AMOXICILLIN\CLAVULANATE POTASSIUM, BEDAQUILINE FUMARATE, CLOFAZIMINE, CYCLOSERINE, ETHAMBUTOL HYDROCHLORIDE, ISONIAZID, LEVOFLOXACIN, LINEZOLID, MEROPENEM, MOXIFLOXACIN, PASINIAZID, PROTIONAMIDE, PYRAZINAMIDE, STREPTOMYCIN SULFATE | DrugsGivenReaction | CC BY-NC | 33515206 | 18,875,374 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Electrolyte imbalance'. | Interim Effectiveness and Safety Comparison of Bedaquiline-Containing Regimens for Treatment of Diabetic Versus Non-Diabetic MDR/XDR-TB Patients in China: A Multicenter Retrospective Cohort Study.
BACKGROUND
Diabetes mellitus (DM), a common tuberculosis (TB) comorbidity, is associated with delayed bacillary clearance d... | AMIKACIN, AMINOSALICYLIC ACID, AMOXICILLIN\CLAVULANATE POTASSIUM, BEDAQUILINE FUMARATE, CLOFAZIMINE, CYCLOSERINE, ETHAMBUTOL HYDROCHLORIDE, ISONIAZID, LEVOFLOXACIN, LINEZOLID, MEROPENEM, MOXIFLOXACIN, PASINIAZID, PROTIONAMIDE, PYRAZINAMIDE, STREPTOMYCIN SULFATE | DrugsGivenReaction | CC BY-NC | 33515206 | 18,875,374 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gastrointestinal disorder'. | Interim Effectiveness and Safety Comparison of Bedaquiline-Containing Regimens for Treatment of Diabetic Versus Non-Diabetic MDR/XDR-TB Patients in China: A Multicenter Retrospective Cohort Study.
BACKGROUND
Diabetes mellitus (DM), a common tuberculosis (TB) comorbidity, is associated with delayed bacillary clearance d... | AMIKACIN, AMINOSALICYLIC ACID, AMOXICILLIN\CLAVULANATE POTASSIUM, BEDAQUILINE FUMARATE, CLOFAZIMINE, CYCLOSERINE, ETHAMBUTOL HYDROCHLORIDE, ISONIAZID, LEVOFLOXACIN, LINEZOLID, MEROPENEM, MOXIFLOXACIN, PASINIAZID, PROTIONAMIDE, PYRAZINAMIDE, STREPTOMYCIN SULFATE | DrugsGivenReaction | CC BY-NC | 33515206 | 18,875,374 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haemoptysis'. | Interim Effectiveness and Safety Comparison of Bedaquiline-Containing Regimens for Treatment of Diabetic Versus Non-Diabetic MDR/XDR-TB Patients in China: A Multicenter Retrospective Cohort Study.
BACKGROUND
Diabetes mellitus (DM), a common tuberculosis (TB) comorbidity, is associated with delayed bacillary clearance d... | AMIKACIN, AMINOSALICYLIC ACID, AMOXICILLIN\CLAVULANATE POTASSIUM, BEDAQUILINE FUMARATE, CLOFAZIMINE, CYCLOSERINE, ETHAMBUTOL HYDROCHLORIDE, ISONIAZID, LEVOFLOXACIN, LINEZOLID, MEROPENEM, MOXIFLOXACIN, PASINIAZID, PROTIONAMIDE, PYRAZINAMIDE, STREPTOMYCIN SULFATE | DrugsGivenReaction | CC BY-NC | 33515206 | 18,875,374 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Headache'. | Interim Effectiveness and Safety Comparison of Bedaquiline-Containing Regimens for Treatment of Diabetic Versus Non-Diabetic MDR/XDR-TB Patients in China: A Multicenter Retrospective Cohort Study.
BACKGROUND
Diabetes mellitus (DM), a common tuberculosis (TB) comorbidity, is associated with delayed bacillary clearance d... | AMIKACIN, AMINOSALICYLIC ACID, AMOXICILLIN\CLAVULANATE POTASSIUM, BEDAQUILINE FUMARATE, CLOFAZIMINE, CYCLOSERINE, ETHAMBUTOL HYDROCHLORIDE, ISONIAZID, LEVOFLOXACIN, LINEZOLID, MEROPENEM, MOXIFLOXACIN, PASINIAZID, PROTIONAMIDE, PYRAZINAMIDE, STREPTOMYCIN SULFATE | DrugsGivenReaction | CC BY-NC | 33515206 | 18,875,374 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hepatotoxicity'. | Interim Effectiveness and Safety Comparison of Bedaquiline-Containing Regimens for Treatment of Diabetic Versus Non-Diabetic MDR/XDR-TB Patients in China: A Multicenter Retrospective Cohort Study.
BACKGROUND
Diabetes mellitus (DM), a common tuberculosis (TB) comorbidity, is associated with delayed bacillary clearance d... | AMIKACIN, AMINOSALICYLIC ACID, AMOXICILLIN\CLAVULANATE POTASSIUM, BEDAQUILINE FUMARATE, CLOFAZIMINE, CYCLOSERINE, ETHAMBUTOL HYDROCHLORIDE, ISONIAZID, LEVOFLOXACIN, LINEZOLID, MEROPENEM, MOXIFLOXACIN, PASINIAZID, PROTIONAMIDE, PYRAZINAMIDE, STREPTOMYCIN SULFATE | DrugsGivenReaction | CC BY-NC | 33515206 | 18,875,374 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Intestinal obstruction'. | Interim Effectiveness and Safety Comparison of Bedaquiline-Containing Regimens for Treatment of Diabetic Versus Non-Diabetic MDR/XDR-TB Patients in China: A Multicenter Retrospective Cohort Study.
BACKGROUND
Diabetes mellitus (DM), a common tuberculosis (TB) comorbidity, is associated with delayed bacillary clearance d... | AMIKACIN, AMINOSALICYLIC ACID, AMOXICILLIN\CLAVULANATE POTASSIUM, BEDAQUILINE FUMARATE, CLOFAZIMINE, CYCLOSERINE, ETHAMBUTOL HYDROCHLORIDE, ISONIAZID, LEVOFLOXACIN, LINEZOLID, MEROPENEM, MOXIFLOXACIN, PASINIAZID, PROTIONAMIDE, PYRAZINAMIDE, STREPTOMYCIN SULFATE | DrugsGivenReaction | CC BY-NC | 33515206 | 18,875,374 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neuropathy peripheral'. | Interim Effectiveness and Safety Comparison of Bedaquiline-Containing Regimens for Treatment of Diabetic Versus Non-Diabetic MDR/XDR-TB Patients in China: A Multicenter Retrospective Cohort Study.
BACKGROUND
Diabetes mellitus (DM), a common tuberculosis (TB) comorbidity, is associated with delayed bacillary clearance d... | AMIKACIN, AMINOSALICYLIC ACID, AMOXICILLIN\CLAVULANATE POTASSIUM, BEDAQUILINE FUMARATE, CLOFAZIMINE, CYCLOSERINE, ETHAMBUTOL HYDROCHLORIDE, ISONIAZID, LEVOFLOXACIN, LINEZOLID, MEROPENEM, MOXIFLOXACIN, PASINIAZID, PROTIONAMIDE, PYRAZINAMIDE, STREPTOMYCIN SULFATE | DrugsGivenReaction | CC BY-NC | 33515206 | 18,875,374 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Optic neuritis'. | Interim Effectiveness and Safety Comparison of Bedaquiline-Containing Regimens for Treatment of Diabetic Versus Non-Diabetic MDR/XDR-TB Patients in China: A Multicenter Retrospective Cohort Study.
BACKGROUND
Diabetes mellitus (DM), a common tuberculosis (TB) comorbidity, is associated with delayed bacillary clearance d... | AMIKACIN, AMINOSALICYLIC ACID, AMOXICILLIN\CLAVULANATE POTASSIUM, BEDAQUILINE FUMARATE, CLOFAZIMINE, CYCLOSERINE, ETHAMBUTOL HYDROCHLORIDE, ISONIAZID, LEVOFLOXACIN, LINEZOLID, MEROPENEM, MOXIFLOXACIN, PASINIAZID, PROTIONAMIDE, PYRAZINAMIDE, STREPTOMYCIN SULFATE | DrugsGivenReaction | CC BY-NC | 33515206 | 18,875,374 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Ototoxicity'. | Interim Effectiveness and Safety Comparison of Bedaquiline-Containing Regimens for Treatment of Diabetic Versus Non-Diabetic MDR/XDR-TB Patients in China: A Multicenter Retrospective Cohort Study.
BACKGROUND
Diabetes mellitus (DM), a common tuberculosis (TB) comorbidity, is associated with delayed bacillary clearance d... | AMIKACIN, AMINOSALICYLIC ACID, AMOXICILLIN\CLAVULANATE POTASSIUM, BEDAQUILINE FUMARATE, CLOFAZIMINE, CYCLOSERINE, ETHAMBUTOL HYDROCHLORIDE, ISONIAZID, LEVOFLOXACIN, LINEZOLID, MEROPENEM, MOXIFLOXACIN, PASINIAZID, PROTIONAMIDE, PYRAZINAMIDE, STREPTOMYCIN SULFATE | DrugsGivenReaction | CC BY-NC | 33515206 | 18,875,374 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Psychiatric symptom'. | Interim Effectiveness and Safety Comparison of Bedaquiline-Containing Regimens for Treatment of Diabetic Versus Non-Diabetic MDR/XDR-TB Patients in China: A Multicenter Retrospective Cohort Study.
BACKGROUND
Diabetes mellitus (DM), a common tuberculosis (TB) comorbidity, is associated with delayed bacillary clearance d... | AMIKACIN, AMINOSALICYLIC ACID, AMOXICILLIN\CLAVULANATE POTASSIUM, BEDAQUILINE FUMARATE, CLOFAZIMINE, CYCLOSERINE, ETHAMBUTOL HYDROCHLORIDE, ISONIAZID, LEVOFLOXACIN, LINEZOLID, MEROPENEM, MOXIFLOXACIN, PASINIAZID, PROTIONAMIDE, PYRAZINAMIDE, STREPTOMYCIN SULFATE | DrugsGivenReaction | CC BY-NC | 33515206 | 18,875,374 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pyrexia'. | Interim Effectiveness and Safety Comparison of Bedaquiline-Containing Regimens for Treatment of Diabetic Versus Non-Diabetic MDR/XDR-TB Patients in China: A Multicenter Retrospective Cohort Study.
BACKGROUND
Diabetes mellitus (DM), a common tuberculosis (TB) comorbidity, is associated with delayed bacillary clearance d... | AMIKACIN, AMINOSALICYLIC ACID, AMOXICILLIN\CLAVULANATE POTASSIUM, BEDAQUILINE FUMARATE, CLOFAZIMINE, CYCLOSERINE, ETHAMBUTOL HYDROCHLORIDE, ISONIAZID, LEVOFLOXACIN, LINEZOLID, MEROPENEM, MOXIFLOXACIN, PASINIAZID, PROTIONAMIDE, PYRAZINAMIDE, STREPTOMYCIN SULFATE | DrugsGivenReaction | CC BY-NC | 33515206 | 18,875,374 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Renal injury'. | Interim Effectiveness and Safety Comparison of Bedaquiline-Containing Regimens for Treatment of Diabetic Versus Non-Diabetic MDR/XDR-TB Patients in China: A Multicenter Retrospective Cohort Study.
BACKGROUND
Diabetes mellitus (DM), a common tuberculosis (TB) comorbidity, is associated with delayed bacillary clearance d... | AMIKACIN, AMINOSALICYLIC ACID, AMOXICILLIN\CLAVULANATE POTASSIUM, BEDAQUILINE FUMARATE, CLOFAZIMINE, CYCLOSERINE, ETHAMBUTOL HYDROCHLORIDE, ISONIAZID, LEVOFLOXACIN, LINEZOLID, MEROPENEM, MOXIFLOXACIN, PASINIAZID, PROTIONAMIDE, PYRAZINAMIDE, STREPTOMYCIN SULFATE | DrugsGivenReaction | CC BY-NC | 33515206 | 18,875,374 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Skin reaction'. | Interim Effectiveness and Safety Comparison of Bedaquiline-Containing Regimens for Treatment of Diabetic Versus Non-Diabetic MDR/XDR-TB Patients in China: A Multicenter Retrospective Cohort Study.
BACKGROUND
Diabetes mellitus (DM), a common tuberculosis (TB) comorbidity, is associated with delayed bacillary clearance d... | AMIKACIN, AMINOSALICYLIC ACID, AMOXICILLIN\CLAVULANATE POTASSIUM, BEDAQUILINE FUMARATE, CLOFAZIMINE, CYCLOSERINE, ETHAMBUTOL HYDROCHLORIDE, ISONIAZID, LEVOFLOXACIN, LINEZOLID, MEROPENEM, MOXIFLOXACIN, PASINIAZID, PROTIONAMIDE, PYRAZINAMIDE, STREPTOMYCIN SULFATE | DrugsGivenReaction | CC BY-NC | 33515206 | 18,875,374 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Syncope'. | Interim Effectiveness and Safety Comparison of Bedaquiline-Containing Regimens for Treatment of Diabetic Versus Non-Diabetic MDR/XDR-TB Patients in China: A Multicenter Retrospective Cohort Study.
BACKGROUND
Diabetes mellitus (DM), a common tuberculosis (TB) comorbidity, is associated with delayed bacillary clearance d... | AMIKACIN, AMINOSALICYLIC ACID, AMOXICILLIN\CLAVULANATE POTASSIUM, BEDAQUILINE FUMARATE, CLOFAZIMINE, CYCLOSERINE, ETHAMBUTOL HYDROCHLORIDE, ISONIAZID, LEVOFLOXACIN, LINEZOLID, MEROPENEM, MOXIFLOXACIN, PASINIAZID, PROTIONAMIDE, PYRAZINAMIDE, STREPTOMYCIN SULFATE | DrugsGivenReaction | CC BY-NC | 33515206 | 18,875,374 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Thyroid disorder'. | Interim Effectiveness and Safety Comparison of Bedaquiline-Containing Regimens for Treatment of Diabetic Versus Non-Diabetic MDR/XDR-TB Patients in China: A Multicenter Retrospective Cohort Study.
BACKGROUND
Diabetes mellitus (DM), a common tuberculosis (TB) comorbidity, is associated with delayed bacillary clearance d... | AMIKACIN, AMINOSALICYLIC ACID, AMOXICILLIN\CLAVULANATE POTASSIUM, BEDAQUILINE FUMARATE, CLOFAZIMINE, CYCLOSERINE, ETHAMBUTOL HYDROCHLORIDE, ISONIAZID, LEVOFLOXACIN, LINEZOLID, MEROPENEM, MOXIFLOXACIN, PASINIAZID, PROTIONAMIDE, PYRAZINAMIDE, STREPTOMYCIN SULFATE | DrugsGivenReaction | CC BY-NC | 33515206 | 18,875,374 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Upper respiratory tract infection'. | Interim Effectiveness and Safety Comparison of Bedaquiline-Containing Regimens for Treatment of Diabetic Versus Non-Diabetic MDR/XDR-TB Patients in China: A Multicenter Retrospective Cohort Study.
BACKGROUND
Diabetes mellitus (DM), a common tuberculosis (TB) comorbidity, is associated with delayed bacillary clearance d... | AMIKACIN, AMINOSALICYLIC ACID, AMOXICILLIN\CLAVULANATE POTASSIUM, BEDAQUILINE FUMARATE, CLOFAZIMINE, CYCLOSERINE, ETHAMBUTOL HYDROCHLORIDE, ISONIAZID, LEVOFLOXACIN, LINEZOLID, MEROPENEM, MOXIFLOXACIN, PASINIAZID, PROTIONAMIDE, PYRAZINAMIDE, STREPTOMYCIN SULFATE | DrugsGivenReaction | CC BY-NC | 33515206 | 18,875,374 | 2021-03 |
What was the administration route of drug 'BEDAQUILINE FUMARATE'? | Interim Effectiveness and Safety Comparison of Bedaquiline-Containing Regimens for Treatment of Diabetic Versus Non-Diabetic MDR/XDR-TB Patients in China: A Multicenter Retrospective Cohort Study.
BACKGROUND
Diabetes mellitus (DM), a common tuberculosis (TB) comorbidity, is associated with delayed bacillary clearance d... | Oral | DrugAdministrationRoute | CC BY-NC | 33515206 | 18,875,374 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Bacterial sepsis'. | Abatacept as salvage therapy in chronic graft-versus-host disease-a retrospective analysis.
The immunomodulatory fusion protein abatacept has recently been investigated for the treatment of steroid-refractory chronic graft-versus-host disease (cGvHD) in a phase 1 clinical trial. We analyzed the safety and efficacy of a... | ABATACEPT | DrugsGivenReaction | CC BY | 33515310 | 18,904,824 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Infection'. | Abatacept as salvage therapy in chronic graft-versus-host disease-a retrospective analysis.
The immunomodulatory fusion protein abatacept has recently been investigated for the treatment of steroid-refractory chronic graft-versus-host disease (cGvHD) in a phase 1 clinical trial. We analyzed the safety and efficacy of a... | ABATACEPT | DrugsGivenReaction | CC BY | 33515310 | 18,904,556 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Intentional product use issue'. | Abatacept as salvage therapy in chronic graft-versus-host disease-a retrospective analysis.
The immunomodulatory fusion protein abatacept has recently been investigated for the treatment of steroid-refractory chronic graft-versus-host disease (cGvHD) in a phase 1 clinical trial. We analyzed the safety and efficacy of a... | ABATACEPT | DrugsGivenReaction | CC BY | 33515310 | 18,904,824 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonia influenzal'. | Abatacept as salvage therapy in chronic graft-versus-host disease-a retrospective analysis.
The immunomodulatory fusion protein abatacept has recently been investigated for the treatment of steroid-refractory chronic graft-versus-host disease (cGvHD) in a phase 1 clinical trial. We analyzed the safety and efficacy of a... | ABATACEPT | DrugsGivenReaction | CC BY | 33515310 | 18,904,711 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Urosepsis'. | Abatacept as salvage therapy in chronic graft-versus-host disease-a retrospective analysis.
The immunomodulatory fusion protein abatacept has recently been investigated for the treatment of steroid-refractory chronic graft-versus-host disease (cGvHD) in a phase 1 clinical trial. We analyzed the safety and efficacy of a... | ABATACEPT | DrugsGivenReaction | CC BY | 33515310 | 18,904,612 | 2021-03 |
What was the administration route of drug 'ABATACEPT'? | Abatacept as salvage therapy in chronic graft-versus-host disease-a retrospective analysis.
The immunomodulatory fusion protein abatacept has recently been investigated for the treatment of steroid-refractory chronic graft-versus-host disease (cGvHD) in a phase 1 clinical trial. We analyzed the safety and efficacy of a... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33515310 | 18,904,824 | 2021-03 |
What was the outcome of reaction 'Bacterial sepsis'? | Abatacept as salvage therapy in chronic graft-versus-host disease-a retrospective analysis.
The immunomodulatory fusion protein abatacept has recently been investigated for the treatment of steroid-refractory chronic graft-versus-host disease (cGvHD) in a phase 1 clinical trial. We analyzed the safety and efficacy of a... | Fatal | ReactionOutcome | CC BY | 33515310 | 18,904,824 | 2021-03 |
What was the outcome of reaction 'Infection'? | Abatacept as salvage therapy in chronic graft-versus-host disease-a retrospective analysis.
The immunomodulatory fusion protein abatacept has recently been investigated for the treatment of steroid-refractory chronic graft-versus-host disease (cGvHD) in a phase 1 clinical trial. We analyzed the safety and efficacy of a... | Fatal | ReactionOutcome | CC BY | 33515310 | 18,904,556 | 2021-03 |
What was the outcome of reaction 'Urosepsis'? | Abatacept as salvage therapy in chronic graft-versus-host disease-a retrospective analysis.
The immunomodulatory fusion protein abatacept has recently been investigated for the treatment of steroid-refractory chronic graft-versus-host disease (cGvHD) in a phase 1 clinical trial. We analyzed the safety and efficacy of a... | Fatal | ReactionOutcome | CC BY | 33515310 | 18,904,612 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Anaemia'. | Early stent thrombosis confirmed in a cancer patient receiving regorafenib, despite triple antithrombotic therapy: a case report.
While developments in oncology have lengthened survival in patients with cancer, such patients often develop cardiovascular diseases. Thus, percutaneous coronary intervention (PCI) is freque... | AMLODIPINE BESYLATE, APIXABAN, ASPIRIN, BISOPROLOL, ENALAPRIL, ESOMEPRAZOLE MAGNESIUM, FUROSEMIDE, INSULIN DEGLUDEC, MITIGLINIDE, PRASUGREL HYDROCHLORIDE, REGORAFENIB, SITAGLIPTIN | DrugsGivenReaction | CC BY | 33516171 | 18,873,767 | 2021-01-30 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiac failure'. | Early stent thrombosis confirmed in a cancer patient receiving regorafenib, despite triple antithrombotic therapy: a case report.
While developments in oncology have lengthened survival in patients with cancer, such patients often develop cardiovascular diseases. Thus, percutaneous coronary intervention (PCI) is freque... | AMLODIPINE BESYLATE, APIXABAN, ASPIRIN, BISOPROLOL, ENALAPRIL, ESOMEPRAZOLE MAGNESIUM, FUROSEMIDE, INSULIN DEGLUDEC, MITIGLINIDE, PRASUGREL HYDROCHLORIDE, REGORAFENIB, SITAGLIPTIN | DrugsGivenReaction | CC BY | 33516171 | 18,873,767 | 2021-01-30 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Colorectal cancer'. | Early stent thrombosis confirmed in a cancer patient receiving regorafenib, despite triple antithrombotic therapy: a case report.
While developments in oncology have lengthened survival in patients with cancer, such patients often develop cardiovascular diseases. Thus, percutaneous coronary intervention (PCI) is freque... | AMLODIPINE BESYLATE, APIXABAN, ASPIRIN, BISOPROLOL, ENALAPRIL, ESOMEPRAZOLE MAGNESIUM, FUROSEMIDE, INSULIN DEGLUDEC, MITIGLINIDE, PRASUGREL HYDROCHLORIDE, REGORAFENIB, SITAGLIPTIN | DrugsGivenReaction | CC BY | 33516171 | 18,873,767 | 2021-01-30 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Early stent thrombosis confirmed in a cancer patient receiving regorafenib, despite triple antithrombotic therapy: a case report.
While developments in oncology have lengthened survival in patients with cancer, such patients often develop cardiovascular diseases. Thus, percutaneous coronary intervention (PCI) is freque... | AMLODIPINE BESYLATE, APIXABAN, ASPIRIN, BISOPROLOL, ENALAPRIL, ESOMEPRAZOLE MAGNESIUM, FUROSEMIDE, INSULIN DEGLUDEC, MITIGLINIDE, PRASUGREL, REGORAFENIB, SITAGLIPTIN | DrugsGivenReaction | CC BY | 33516171 | 18,888,660 | 2021-01-30 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Glycosylated haemoglobin increased'. | Early stent thrombosis confirmed in a cancer patient receiving regorafenib, despite triple antithrombotic therapy: a case report.
While developments in oncology have lengthened survival in patients with cancer, such patients often develop cardiovascular diseases. Thus, percutaneous coronary intervention (PCI) is freque... | AMLODIPINE BESYLATE, APIXABAN, ASPIRIN, BISOPROLOL, ENALAPRIL, ESOMEPRAZOLE MAGNESIUM, FUROSEMIDE, INSULIN DEGLUDEC, MITIGLINIDE, PRASUGREL HYDROCHLORIDE, REGORAFENIB, SITAGLIPTIN | DrugsGivenReaction | CC BY | 33516171 | 18,873,767 | 2021-01-30 |
What is the weight of the patient? | Early stent thrombosis confirmed in a cancer patient receiving regorafenib, despite triple antithrombotic therapy: a case report.
While developments in oncology have lengthened survival in patients with cancer, such patients often develop cardiovascular diseases. Thus, percutaneous coronary intervention (PCI) is freque... | 75 kg. | Weight | CC BY | 33516171 | 18,873,767 | 2021-01-30 |
What was the dosage of drug 'INSULIN DEGLUDEC'? | Early stent thrombosis confirmed in a cancer patient receiving regorafenib, despite triple antithrombotic therapy: a case report.
While developments in oncology have lengthened survival in patients with cancer, such patients often develop cardiovascular diseases. Thus, percutaneous coronary intervention (PCI) is freque... | 9 UNITS | DrugDosageText | CC BY | 33516171 | 18,873,767 | 2021-01-30 |
What was the outcome of reaction 'Cardiac failure'? | Early stent thrombosis confirmed in a cancer patient receiving regorafenib, despite triple antithrombotic therapy: a case report.
While developments in oncology have lengthened survival in patients with cancer, such patients often develop cardiovascular diseases. Thus, percutaneous coronary intervention (PCI) is freque... | Recovered | ReactionOutcome | CC BY | 33516171 | 18,873,767 | 2021-01-30 |
What was the outcome of reaction 'Colorectal cancer'? | Early stent thrombosis confirmed in a cancer patient receiving regorafenib, despite triple antithrombotic therapy: a case report.
While developments in oncology have lengthened survival in patients with cancer, such patients often develop cardiovascular diseases. Thus, percutaneous coronary intervention (PCI) is freque... | Fatal | ReactionOutcome | CC BY | 33516171 | 18,873,767 | 2021-01-30 |
What was the outcome of reaction 'Vascular stent thrombosis'? | Early stent thrombosis confirmed in a cancer patient receiving regorafenib, despite triple antithrombotic therapy: a case report.
While developments in oncology have lengthened survival in patients with cancer, such patients often develop cardiovascular diseases. Thus, percutaneous coronary intervention (PCI) is freque... | Recovered | ReactionOutcome | CC BY | 33516171 | 18,873,767 | 2021-01-30 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Clonal evolution'. | Outgrowth of a CSF3R-mutant clone drives a second myeloproliferative neoplasm in a chronic myeloid leukemia patient: a case report.
BACKGROUND
Chronic myeloid leukemia (CML) and chronic neutrophilic leukemia (CNL) are two myeloproliferative neoplasms with mutually exclusive diagnostic criteria. A hallmark of CML is the... | PONATINIB | DrugsGivenReaction | CC BY | 33516272 | 19,168,698 | 2021-01-30 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gene mutation'. | Outgrowth of a CSF3R-mutant clone drives a second myeloproliferative neoplasm in a chronic myeloid leukemia patient: a case report.
BACKGROUND
Chronic myeloid leukemia (CML) and chronic neutrophilic leukemia (CNL) are two myeloproliferative neoplasms with mutually exclusive diagnostic criteria. A hallmark of CML is the... | DASATINIB, IMATINIB MESYLATE, NILOTINIB | DrugsGivenReaction | CC BY | 33516272 | 19,082,195 | 2021-01-30 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Myeloproliferative neoplasm'. | Outgrowth of a CSF3R-mutant clone drives a second myeloproliferative neoplasm in a chronic myeloid leukemia patient: a case report.
BACKGROUND
Chronic myeloid leukemia (CML) and chronic neutrophilic leukemia (CNL) are two myeloproliferative neoplasms with mutually exclusive diagnostic criteria. A hallmark of CML is the... | DASATINIB, IMATINIB MESYLATE, NILOTINIB, PONATINIB | DrugsGivenReaction | CC BY | 33516272 | 19,132,277 | 2021-01-30 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neutrophil count increased'. | Outgrowth of a CSF3R-mutant clone drives a second myeloproliferative neoplasm in a chronic myeloid leukemia patient: a case report.
BACKGROUND
Chronic myeloid leukemia (CML) and chronic neutrophilic leukemia (CNL) are two myeloproliferative neoplasms with mutually exclusive diagnostic criteria. A hallmark of CML is the... | PONATINIB | DrugsGivenReaction | CC BY | 33516272 | 19,168,698 | 2021-01-30 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neutrophilia'. | Outgrowth of a CSF3R-mutant clone drives a second myeloproliferative neoplasm in a chronic myeloid leukemia patient: a case report.
BACKGROUND
Chronic myeloid leukemia (CML) and chronic neutrophilic leukemia (CNL) are two myeloproliferative neoplasms with mutually exclusive diagnostic criteria. A hallmark of CML is the... | DASATINIB, IMATINIB MESYLATE, NILOTINIB, PONATINIB | DrugsGivenReaction | CC BY | 33516272 | 19,132,277 | 2021-01-30 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Outgrowth of a CSF3R-mutant clone drives a second myeloproliferative neoplasm in a chronic myeloid leukemia patient: a case report.
BACKGROUND
Chronic myeloid leukemia (CML) and chronic neutrophilic leukemia (CNL) are two myeloproliferative neoplasms with mutually exclusive diagnostic criteria. A hallmark of CML is the... | PONATINIB | DrugsGivenReaction | CC BY | 33516272 | 19,168,698 | 2021-01-30 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'White blood cell count increased'. | Outgrowth of a CSF3R-mutant clone drives a second myeloproliferative neoplasm in a chronic myeloid leukemia patient: a case report.
BACKGROUND
Chronic myeloid leukemia (CML) and chronic neutrophilic leukemia (CNL) are two myeloproliferative neoplasms with mutually exclusive diagnostic criteria. A hallmark of CML is the... | PONATINIB | DrugsGivenReaction | CC BY | 33516272 | 19,168,698 | 2021-01-30 |
What was the outcome of reaction 'Myeloproliferative neoplasm'? | Outgrowth of a CSF3R-mutant clone drives a second myeloproliferative neoplasm in a chronic myeloid leukemia patient: a case report.
BACKGROUND
Chronic myeloid leukemia (CML) and chronic neutrophilic leukemia (CNL) are two myeloproliferative neoplasms with mutually exclusive diagnostic criteria. A hallmark of CML is the... | Recovering | ReactionOutcome | CC BY | 33516272 | 19,132,277 | 2021-01-30 |
What was the outcome of reaction 'Neutrophilia'? | Outgrowth of a CSF3R-mutant clone drives a second myeloproliferative neoplasm in a chronic myeloid leukemia patient: a case report.
BACKGROUND
Chronic myeloid leukemia (CML) and chronic neutrophilic leukemia (CNL) are two myeloproliferative neoplasms with mutually exclusive diagnostic criteria. A hallmark of CML is the... | Recovering | ReactionOutcome | CC BY | 33516272 | 19,132,277 | 2021-01-30 |
What was the outcome of reaction 'Thrombocytopenia'? | Outgrowth of a CSF3R-mutant clone drives a second myeloproliferative neoplasm in a chronic myeloid leukemia patient: a case report.
BACKGROUND
Chronic myeloid leukemia (CML) and chronic neutrophilic leukemia (CNL) are two myeloproliferative neoplasms with mutually exclusive diagnostic criteria. A hallmark of CML is the... | Recovering | ReactionOutcome | CC BY | 33516272 | 19,132,277 | 2021-01-30 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Renal impairment'. | Renal medication-related clinical decision support (CDS) alerts and overrides in the inpatient setting following implementation of a commercial electronic health record: implications for designing more effective alerts.
To assess the appropriateness of medication-related clinical decision support (CDS) alerts associate... | FUROSEMIDE | DrugsGivenReaction | CC BY-NC | 33517413 | 19,969,718 | 2021-06-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Ankylosing spondylitis'. | Post-transplant manifestation of ankylosing spondylitis: a case report and review of literature.
Ankylosing spondylitis (AS) is an insidiously progressive and debilitating form of arthritis involving the axial skeleton, characterized by chronic back pain and progressive spinal stiffness, and lessening of pain and stiff... | BETAMETHASONE DIPROPIONATE, CLINDAMYCIN PHOSPHATE, CYCLOSPORINE, LIDOCAINE HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, PREDNISONE, SULFASALAZINE, VANCOMYCIN HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33517879 | 18,915,565 | 2021-01-31 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Arthralgia'. | Post-transplant manifestation of ankylosing spondylitis: a case report and review of literature.
Ankylosing spondylitis (AS) is an insidiously progressive and debilitating form of arthritis involving the axial skeleton, characterized by chronic back pain and progressive spinal stiffness, and lessening of pain and stiff... | CYCLOSPORINE, MYCOPHENOLATE MOFETIL, PREDNISONE | DrugsGivenReaction | CC BY | 33517879 | 19,003,793 | 2021-01-31 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Chronic kidney disease'. | Post-transplant manifestation of ankylosing spondylitis: a case report and review of literature.
Ankylosing spondylitis (AS) is an insidiously progressive and debilitating form of arthritis involving the axial skeleton, characterized by chronic back pain and progressive spinal stiffness, and lessening of pain and stiff... | BETAMETHASONE DIPROPIONATE, CLINDAMYCIN PHOSPHATE, CYCLOSPORINE, LIDOCAINE HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, PREDNISONE, SULFASALAZINE, VANCOMYCIN HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33517879 | 18,915,565 | 2021-01-31 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Joint effusion'. | Post-transplant manifestation of ankylosing spondylitis: a case report and review of literature.
Ankylosing spondylitis (AS) is an insidiously progressive and debilitating form of arthritis involving the axial skeleton, characterized by chronic back pain and progressive spinal stiffness, and lessening of pain and stiff... | CYCLOSPORINE, MYCOPHENOLATE MOFETIL, PREDNISONE | DrugsGivenReaction | CC BY | 33517879 | 19,003,793 | 2021-01-31 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Joint warmth'. | Post-transplant manifestation of ankylosing spondylitis: a case report and review of literature.
Ankylosing spondylitis (AS) is an insidiously progressive and debilitating form of arthritis involving the axial skeleton, characterized by chronic back pain and progressive spinal stiffness, and lessening of pain and stiff... | CYCLOSPORINE, MYCOPHENOLATE MOFETIL, PREDNISONE | DrugsGivenReaction | CC BY | 33517879 | 19,003,793 | 2021-01-31 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Oedema peripheral'. | Post-transplant manifestation of ankylosing spondylitis: a case report and review of literature.
Ankylosing spondylitis (AS) is an insidiously progressive and debilitating form of arthritis involving the axial skeleton, characterized by chronic back pain and progressive spinal stiffness, and lessening of pain and stiff... | CYCLOSPORINE, MYCOPHENOLATE MOFETIL, PREDNISONE | DrugsGivenReaction | CC BY | 33517879 | 19,003,793 | 2021-01-31 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pain'. | Post-transplant manifestation of ankylosing spondylitis: a case report and review of literature.
Ankylosing spondylitis (AS) is an insidiously progressive and debilitating form of arthritis involving the axial skeleton, characterized by chronic back pain and progressive spinal stiffness, and lessening of pain and stiff... | CYCLOSPORINE, MYCOPHENOLATE MOFETIL, PREDNISONE | DrugsGivenReaction | CC BY | 33517879 | 19,003,793 | 2021-01-31 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Post-transplant manifestation of ankylosing spondylitis: a case report and review of literature.
Ankylosing spondylitis (AS) is an insidiously progressive and debilitating form of arthritis involving the axial skeleton, characterized by chronic back pain and progressive spinal stiffness, and lessening of pain and stiff... | BETAMETHASONE DIPROPIONATE, CLINDAMYCIN PHOSPHATE, CYCLOSPORINE, LIDOCAINE HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, PREDNISONE, SULFASALAZINE, VANCOMYCIN HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33517879 | 18,915,565 | 2021-01-31 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Proteinuria'. | Post-transplant manifestation of ankylosing spondylitis: a case report and review of literature.
Ankylosing spondylitis (AS) is an insidiously progressive and debilitating form of arthritis involving the axial skeleton, characterized by chronic back pain and progressive spinal stiffness, and lessening of pain and stiff... | BETAMETHASONE DIPROPIONATE, CLINDAMYCIN PHOSPHATE, CYCLOSPORINE, LIDOCAINE HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, PREDNISONE, SULFASALAZINE, VANCOMYCIN HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33517879 | 18,915,565 | 2021-01-31 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pyrexia'. | Post-transplant manifestation of ankylosing spondylitis: a case report and review of literature.
Ankylosing spondylitis (AS) is an insidiously progressive and debilitating form of arthritis involving the axial skeleton, characterized by chronic back pain and progressive spinal stiffness, and lessening of pain and stiff... | CYCLOSPORINE, MYCOPHENOLATE MOFETIL, PREDNISONE | DrugsGivenReaction | CC BY | 33517879 | 19,003,793 | 2021-01-31 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Septic arthritis streptococcal'. | Post-transplant manifestation of ankylosing spondylitis: a case report and review of literature.
Ankylosing spondylitis (AS) is an insidiously progressive and debilitating form of arthritis involving the axial skeleton, characterized by chronic back pain and progressive spinal stiffness, and lessening of pain and stiff... | CYCLOSPORINE, MYCOPHENOLATE MOFETIL, PREDNISONE | DrugsGivenReaction | CC BY | 33517879 | 19,794,934 | 2021-01-31 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Streptococcal infection'. | Post-transplant manifestation of ankylosing spondylitis: a case report and review of literature.
Ankylosing spondylitis (AS) is an insidiously progressive and debilitating form of arthritis involving the axial skeleton, characterized by chronic back pain and progressive spinal stiffness, and lessening of pain and stiff... | CYCLOSPORINE, MYCOPHENOLATE MOFETIL, PREDNISONE | DrugsGivenReaction | CC BY | 33517879 | 19,794,934 | 2021-01-31 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Tenderness'. | Post-transplant manifestation of ankylosing spondylitis: a case report and review of literature.
Ankylosing spondylitis (AS) is an insidiously progressive and debilitating form of arthritis involving the axial skeleton, characterized by chronic back pain and progressive spinal stiffness, and lessening of pain and stiff... | CYCLOSPORINE, MYCOPHENOLATE MOFETIL, PREDNISONE | DrugsGivenReaction | CC BY | 33517879 | 19,003,793 | 2021-01-31 |
What was the administration route of drug 'BETAMETHASONE DIPROPIONATE'? | Post-transplant manifestation of ankylosing spondylitis: a case report and review of literature.
Ankylosing spondylitis (AS) is an insidiously progressive and debilitating form of arthritis involving the axial skeleton, characterized by chronic back pain and progressive spinal stiffness, and lessening of pain and stiff... | Intrathecal | DrugAdministrationRoute | CC BY | 33517879 | 18,915,565 | 2021-01-31 |
What was the administration route of drug 'LIDOCAINE HYDROCHLORIDE'? | Post-transplant manifestation of ankylosing spondylitis: a case report and review of literature.
Ankylosing spondylitis (AS) is an insidiously progressive and debilitating form of arthritis involving the axial skeleton, characterized by chronic back pain and progressive spinal stiffness, and lessening of pain and stiff... | Intrathecal | DrugAdministrationRoute | CC BY | 33517879 | 18,915,565 | 2021-01-31 |
What was the administration route of drug 'SULFASALAZINE'? | Post-transplant manifestation of ankylosing spondylitis: a case report and review of literature.
Ankylosing spondylitis (AS) is an insidiously progressive and debilitating form of arthritis involving the axial skeleton, characterized by chronic back pain and progressive spinal stiffness, and lessening of pain and stiff... | Oral | DrugAdministrationRoute | CC BY | 33517879 | 18,915,565 | 2021-01-31 |
What was the dosage of drug 'SULFASALAZINE'? | Post-transplant manifestation of ankylosing spondylitis: a case report and review of literature.
Ankylosing spondylitis (AS) is an insidiously progressive and debilitating form of arthritis involving the axial skeleton, characterized by chronic back pain and progressive spinal stiffness, and lessening of pain and stiff... | 500 mg (milligrams). | DrugDosage | CC BY | 33517879 | 18,915,565 | 2021-01-31 |
What was the outcome of reaction 'Ankylosing spondylitis'? | Post-transplant manifestation of ankylosing spondylitis: a case report and review of literature.
Ankylosing spondylitis (AS) is an insidiously progressive and debilitating form of arthritis involving the axial skeleton, characterized by chronic back pain and progressive spinal stiffness, and lessening of pain and stiff... | Recovered | ReactionOutcome | CC BY | 33517879 | 18,915,565 | 2021-01-31 |
What was the outcome of reaction 'Arthralgia'? | Post-transplant manifestation of ankylosing spondylitis: a case report and review of literature.
Ankylosing spondylitis (AS) is an insidiously progressive and debilitating form of arthritis involving the axial skeleton, characterized by chronic back pain and progressive spinal stiffness, and lessening of pain and stiff... | Recovered | ReactionOutcome | CC BY | 33517879 | 19,003,793 | 2021-01-31 |
What was the outcome of reaction 'Joint effusion'? | Post-transplant manifestation of ankylosing spondylitis: a case report and review of literature.
Ankylosing spondylitis (AS) is an insidiously progressive and debilitating form of arthritis involving the axial skeleton, characterized by chronic back pain and progressive spinal stiffness, and lessening of pain and stiff... | Recovered | ReactionOutcome | CC BY | 33517879 | 19,003,793 | 2021-01-31 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.